Genomic Instability - 18 Studies Found Recruiting : A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors : Solid Tumor Microsatellite Instability-High (MSI-H) Solid Tumors Drug: LY3300054 Administered I Recruiting : Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) : Colorectal Carcinoma : 2015-09-28 : Drug: mFOLFOX6 Regimen consist Active, not recruiting : Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) : Colorectal Carcinoma : 2015-05-29 : Biological: Pembrolizumab IV infusion Other Names: Recruiting : A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202) : Malignant Solid Tumor Lymphoma, Large B-Cell, Diffuse Carc : 2014-06-26 : Drug: MK-3475 IV infusion Completed : Molecular Biology of Anal Cancer in HIV-Positive Patients : Carcinoma HIV Infections : 2009-08-03 Completed : Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status : Colorectal Cancer : 2009-05-28 : Drug: olaparib 400 mg po bid continuously Completed : Genetic Study of Young Patients With Colorectal Cancer : Colorectal Cancer : 2002-09-06 : Genetic: microsatellite instability analysis Recruiting : Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity : Non-small Cell Lung Cancer : 2014-12-05 : Drug: MPDL3280A Intravenous (I <<< Previous
